Early-stage prostate cancer diagnostic test utilizing advanced glycan analysis for highly accurate detection. Designed to identify prostate cancer at initial stages, enabling timely clinical intervention and improved patient outcomes.
Manufactured by
Glycanostics, s.r.o.
Bratislava, Slovakia
At Glycanostics, our aim is to develop, clinically validate register an affordable, non-invasive next-gen liquid biopsy prostate cancer diagnostic test with accuracy of up to 90%.
© 2026 Suplivia · Home · Browse Products